Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Perou CM, Sørlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumors. Nature. 2000;406:747–52.

Article  ADS  CAS  PubMed  Google Scholar 

Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn H-J. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22:1736–47.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lakhani SR, International Agency for Research on Cancer. WHO classification of breast tumors. 2nd ed. Who Classification of Tumors Editorial Board, editor. IARC; 2019.

de Azambuja E, Cardoso F, de Castro G, Mano MS, Durbecq V, et al. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients. Br J Cancer. 2007;96:1504–13.

Article  PubMed  PubMed Central  Google Scholar 

Thomssen C, Balic M, Harbeck N, Gnant MS, Gallen V. A brief summary of the consensus discussion on customizing therapies for women with early breast cancer. Breast Care. 2021;2021(16):135–43.

Article  Google Scholar 

Jiang L, Ma T, Moran MS, Kong X, Li X, Haffty BG, et al. Mammographic features are associated with clinicopathological characteristics in invasive breast cancer. Anticancer Res. 2011;31:2327–34.

CAS  PubMed  Google Scholar 

Cheng C, Zhao H, Tian W, Hu C, Zhao H. Predicting the expression level of Ki-67 in breast cancer using multi-modal ultrasound parameters. BMC Med Imaging. 2021;21:150.

Article  PubMed  PubMed Central  Google Scholar 

Fang J, Zhao W, Li Q, Zhang B, Pu C, Wang H. Correlation analysis of conventional ultrasound characteristics and strain elastography with Ki-67 status in breast cancer. Ultrasound Med Biol. 2020;46:2972–8.

Article  PubMed  Google Scholar 

Surov A, Clauser P, Chang Y-W, Li L, Martincich L, Partridge SC, et al. Can diffusion-weighted imaging predict tumor grade and expression of Ki-67 in breast cancer? A multicenter analysis. Breast Cancer Res. 2018;20:58.

Article  PubMed  PubMed Central  Google Scholar 

Ma W, Ji Y, Qi L, Guo X, Jian X, Liu P. Breast cancer Ki67 expression prediction by DCE-MRI radiomics features. Clin Radiol. 2018;73:909.e1-909.e5.

Article  CAS  PubMed  Google Scholar 

Tagliafico AS, Bignotti B, Rossi F, Matos J, Calabrese M, Valdora F, et al. Breast cancer Ki-67 expression prediction by digital breast tomosynthesis radiomics features. Eur Radiol Exp. 2019;3:36.

Article  PubMed  PubMed Central  Google Scholar 

Truhn D, Schrading S, Haarburger C, Schneider H, Merhof D, Kuhl C. Radiomic versus convolutional neural networks analysis for classification of contrast-enhancing lesions at multiparametric breast MRI. Radiology. 2019;290:290–7.

Article  PubMed  Google Scholar 

Gao Y, Moy L, Heller SL. Digital breast tomosynthesis: update on technology, evidence, and clinical practice. Radiographics. 2021;41:321–37.

Article  PubMed  Google Scholar 

Mikami Y, Ueno T, Yoshimura K, Tsuda H, Kurosumi M, Masuda S, et al. Interobserver concordance of Ki67 labeling index in breast cancer: Japan Breast Cancer Research Group Ki67 ring study. Cancer Sci. 2013;104:1539–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gudlaugsson E, Skaland I, Janssen EAM, Smaaland R, Shao Z, Malpica A, et al. Comparison of the effect of different techniques for measurement of Ki67 proliferation on reproducibility and prognosis prediction accuracy in breast cancer. Histopathology. 2012;61:1134–44.

Article  PubMed  Google Scholar 

Jonat W, Arnold N. Is the Ki-67 labelling index ready for clinical use? Ann Oncol. 2011;22:500–2.

Article  CAS  PubMed  Google Scholar 

Polley M-YC, Leung SCY, McShane LM, Gao D, Hugh JC, Mastropasqua MG, et al. An international Ki67 reproducibility study. J Natl Cancer Inst. 2013;105:1897–906.

Article  PubMed  PubMed Central  Google Scholar 

Varga Z, Diebold J, Dommann-Scherrer C, Frick H, Kaup D, Noske A, et al. How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists. PLoS ONE. 2012;7: e37379.

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Chollet F. Xception: Deep Learning with Depthwise Separable Convolutions. IEEE Conf Comp Vis Pattern Recogn (CVPR). 2017;2017:1800–7.

Google Scholar 

Deng J, Dong W, Socher R, Li L-J, Li K, Fei-Fei L. ImageNet: A large-scale hierarchical image database. 2009;248–255.

Liu L, Jiang H, He P, Chen W, Liu X, Gao J, et al. On the Variance of the Adaptive Learning Rate and Beyond [Internet]. arXiv [cs.LG]. 2019; Available from: http://arxiv.org/abs/1908.03265

Jiang T, Jiang W, Chang S, Wang H, Niu S. Intratumoral analysis of digital breast tomosynthesis for predicting the Ki‐67 level in breast cancer: A multi‐center radiomics study. Medical [Internet]. 2022; Available from: https://aapm.onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1002/mp.15392

Zwanenburg A, Leger S, Agolli L, Pilz K, Troost EGC, Richter C, et al. Assessing robustness of radiomic features by image perturbation. Sci Rep. 2019;9:614.

Article  ADS  PubMed  PubMed Central  Google Scholar 

Amer HA, Schmitzberger F, Ingold-Heppner B, Kussmaul J, El Tohamy MF, Tantawy HI, et al. Digital breast tomosynthesis versus full-field digital mammography-Which modality provides more accurate prediction of margin status in specimen radiography? Eur J Radiol. 2017;93:258–64.

Article  PubMed  Google Scholar 

Shimokawa D, Takahashi K, Oba K, Takaya E, Usuzaki T, Kadowaki M, et al. Deep learning model for predicting the presence of stromal invasion of breast cancer on digital breast tomosynthesis. Radiol Phys Technol. 2023. https://doi.org/10.1007/s12194-023-00731-4.

Article  PubMed  Google Scholar 

Bustreo S, Osella-Abate S, Cassoni P, Donadio M, Airoldi M, Pedani F, et al. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up. Breast Cancer Res Treat. 2016;157:363–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, et al. Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE). J Clin Oncol. 2020;38:3987–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Honma N, Yoshida M, Kinowaki K, Horii R, Katsurada Y, Murata Y, et al. (2023) The Japanese breast cancer society clinical practice guidelines for pathological diagnosis of breast cancer, 2022 edition. Breast Cancer, doi: https://doi.org/10.1007/s12282-023-01518-6.